Wednesday, April 12, 2006

Comparison of Schizophrenia Drugs Often Favors Firm Funding Study

Surprised?
Comparison of Schizophrenia Drugs Often Favors Firm Funding Study: "In fact, when psychiatrist John Davis analyzed every publicly available trial funded by the pharmaceutical industry pitting five new antipsychotic drugs against one another, nine in 10 showed that the best drug was the one made by the company funding the study."

No comments:

Related Posts with Thumbnails

ShareThis